CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice-Reference-Cited by-同舟云学术

CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice

Published:2008-09 Issue:1 Volume:39 Page:8-20
ISSN:1044-7431
Container-title:Molecular and Cellular Neuroscience
language:en
Short-container-title:Molecular and Cellular Neuroscience

Author:

Apostol Barbara L.,Simmons Danielle A.,Zuccato Chiara,Illes Katalin,Pallos Judit,Casale Malcolm,Conforti Paola,Ramos Catarina,Roarke Margaret,Kathuria Satish,Cattaneo Elena,Marsh J. Lawrence,Thompson Leslie Michels

Publisher

Elsevier BV

Subject

Cell Biology,Cellular and Molecular Neuroscience,Molecular Biology

Reference87 articles.

1. A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila;Apostol;Proc. Natl. Acad. Sci. U. S. A.,2003

2. Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity;Apostol;Hum. Mol. Genet.,2006

3. Huntington's Disease, Third Edition edn;Bates,2002

4. The Drosophila rolled locus encodes a MAP kinase required in the sevenless signal transduction pathway;Biggs;EMBO J.,1994

5. Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential;Bogoyevitch;Biochim. Biophys. Acta,2004

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of JNK3 in Epilepsy and Neurodegeneration;Pharmacoresistance in Epilepsy;2023

2. p21-Activated kinase 1 (PAK1) in aging and longevity: An overview;Ageing Research Reviews;2021-11

3. Selective Neuron Vulnerability in Common and Rare Diseases—Mitochondria in the Focus;Frontiers in Molecular Biosciences;2021-06-30

4. Exposure of R6/2 mice in an enriched environment augments P42 therapy efficacy on Huntington's disease progression;Neuropharmacology;2021-03

5. Recent approaches to target apoptosis in neurological disorders;Clinical Perspectives and Targeted Therapies in Apoptosis;2021